Literature DB >> 20498680

Histological characteristics of the index lesion in whole-mount radical prostatectomy specimens: implications for focal therapy.

M Karavitakis1, M Winkler, P Abel, N Livni, I Beckley, H U Ahmed.   

Abstract

It has been suggested that in multifocal prostate cancer (PCa), focal therapy to the largest (index) lesion is sufficient, because secondary non-index lesions are unlikely to contribute to disease progression. In this study, the role of PCa focality in selecting men for focal therapy was evaluated. A histopathological analysis of the index and non-index lesions of 100 consecutive radical prostatectomy specimens was carried out. Cases that would have been suitable for focal ablation were also evaluated. Tumours were more often multifocal (78%) and bilateral (86%). In total, 270 tumour foci were identified. In multifocal disease, tumour volume, Gleason score and pathological stage were almost invariably defined by the index lesion of the specimen; among the 170 satellite foci, 148 (87%) were <0.5 cm(3) and 169 (99.4%) had Gleason score ≤ 6. Using the defined criteria, 51% of men in this series would have been considered suitable for focal ablation of the index lesion. Histological features of poor prognosis in the prostate are associated with the index lesion. There is a high proportion of patients who may be suitable for focal therapy, and clinical trials of index lesion ablation should be considered as part of this therapeutic strategy.

Entities:  

Mesh:

Year:  2010        PMID: 20498680     DOI: 10.1038/pcan.2010.16

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  24 in total

Review 1.  Focal therapy of prostate cancer: evidence-based analysis for modern selection criteria.

Authors:  Michael R Abern; Matvey Tsivian; Thomas J Polascik
Journal:  Curr Urol Rep       Date:  2012-04       Impact factor: 3.092

2.  Computed diffusion-weighted imaging of the prostate at 3 T: impact on image quality and tumour detection.

Authors:  Andrew B Rosenkrantz; Hersh Chandarana; Nicole Hindman; Fang-Ming Deng; James S Babb; Samir S Taneja; Christian Geppert
Journal:  Eur Radiol       Date:  2013-06-12       Impact factor: 5.315

Review 3.  [Focal therapy for prostate cancer].

Authors:  M Schostak
Journal:  Urologe A       Date:  2019-05       Impact factor: 0.639

4.  Role of MRI for the detection of prostate cancer.

Authors:  Richard C Wu; Amir H Lebastchi; Boris A Hadaschik; Mark Emberton; Caroline Moore; Pilar Laguna; Jurgen J Fütterer; Arvin K George
Journal:  World J Urol       Date:  2021-01-04       Impact factor: 4.226

5.  Identification of the prostate cancer index lesion by real-time elastography: considerations for focal therapy of prostate cancer.

Authors:  Jochen Walz; Myriam Marcy; Jeanne Thomassin Pianna; Serge Brunelle; Gwenaelle Gravis; Naji Salem; Franck Bladou
Journal:  World J Urol       Date:  2011-05-26       Impact factor: 4.226

6.  Establishing the distribution of satellite lesions in intermediate- and high-risk prostate cancer: implications for focused radiotherapy.

Authors:  J V Hegde; D J Margolis; P-C Wang; R E Reiter; J Huang; M L Steinberg; M Kamrava
Journal:  Prostate Cancer Prostatic Dis       Date:  2017-01-31       Impact factor: 5.554

Review 7.  Benchmarks for success in focal therapy of prostate cancer: cure or control?

Authors:  Hashim U Ahmed; Mark Emberton
Journal:  World J Urol       Date:  2010-09-10       Impact factor: 4.226

Review 8.  Focal therapy in prostate cancer: modalities, findings and future considerations.

Authors:  Uri Lindner; John Trachtenberg; Nathan Lawrentschuk
Journal:  Nat Rev Urol       Date:  2010-09-14       Impact factor: 14.432

Review 9.  Considerations for patient selection for focal therapy.

Authors:  John F Ward; Louis L Pisters
Journal:  Ther Adv Urol       Date:  2013-12

10.  Endorectal MRI and MR spectroscopic imaging of prostate cancer: developing selection criteria for MR-guided focal therapy.

Authors:  Stephanie T Chang; Antonio C Westphalen; Priyanka Jha; Adam J Jung; Peter R Carroll; John Kurhanewicz; Fergus V Coakley
Journal:  J Magn Reson Imaging       Date:  2013-05-16       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.